Longevity Health Holdings, Inc. (XAGE) - Net Assets
Based on the latest financial reports, Longevity Health Holdings, Inc. (XAGE) has net assets worth $-5.87 Million USD as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($2.37 Million) and total liabilities ($8.23 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check how tangible is Longevity Health Holdings, Inc.'s equity to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-5.87 Million |
| % of Total Assets | -247.86% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Longevity Health Holdings, Inc. - Net Assets Trend (2021–2025)
This chart illustrates how Longevity Health Holdings, Inc.'s net assets have evolved over time, based on quarterly financial data. See XAGE defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for Longevity Health Holdings, Inc. (2021–2025)
The table below shows the annual net assets of Longevity Health Holdings, Inc. from 2021 to 2025. For live valuation and market cap data, see XAGE market cap.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $-5.87 Million | -24.49% |
| 2024-12-31 | $-4.71 Million | -119.04% |
| 2023-12-31 | $24.75 Million | +165.49% |
| 2022-12-31 | $-37.79 Million | -27.77% |
| 2021-12-31 | $-29.58 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Longevity Health Holdings, Inc.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 4300248800.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $178.00 | % |
| Other Components | $69.91 Million | % |
| Total Equity | $-5.87 Million | 100.00% |
Longevity Health Holdings, Inc. Competitors by Market Cap
The table below lists competitors of Longevity Health Holdings, Inc. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
STMicroelectronics NV
LSE:0INB
|
$737.88K |
|
Premier Miton Group plc
LSE:PMI
|
$738.17K |
|
First Tin PLC
LSE:1SN
|
$738.41K |
|
Crystal Amber Fund Limited
LSE:CRS
|
$739.71K |
|
Mongolia Growth Group Ltd.
V:YAK-H
|
$736.66K |
|
XXL Energy Corp
V:XL
|
$734.53K |
|
T-Bull S.A
WAR:TBL
|
$732.57K |
|
Lucky Minerals Inc
V:LKY
|
$731.54K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Longevity Health Holdings, Inc.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from -4,712,662 to -5,866,873, a change of -1,154,211.
- Net loss of 6,905,282 reduced equity.
- New share issuances of 3,483,790 increased equity.
- Other factors increased equity by 2,267,281.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-6.91 Million | -117.7% |
| Share Issuances | $3.48 Million | +59.38% |
| Other Changes | $2.27 Million | +38.65% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Longevity Health Holdings, Inc.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2021-12-31 | $-1.50 | $0.30 | x |
| 2022-12-31 | $-1.91 | $0.30 | x |
| 2023-12-31 | $1.19 | $0.30 | x |
| 2024-12-31 | $-0.23 | $0.30 | x |
| 2025-12-31 | $-3.40 | $0.30 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Longevity Health Holdings, Inc. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -361.00%
- • Asset Turnover: 0.81x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-12.48%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2021 | 0.00% | 0.00% | 0.00x | 0.00x | $-3.52 Million |
| 2022 | 0.00% | 0.00% | 0.00x | 0.00x | $-5.27 Million |
| 2023 | -62.41% | 0.00% | 0.00x | 2.58x | $-17.92 Million |
| 2024 | 0.00% | -20605.47% | 0.03x | 0.00x | $-9.90 Million |
| 2025 | 0.00% | -361.00% | 0.81x | 0.00x | $-6.32 Million |
Industry Comparison
This section compares Longevity Health Holdings, Inc.'s net assets metrics with peer companies in the Household & Personal Products industry.
Industry Context
- Industry: Household & Personal Products
- Average net assets among peers: $681,211,031
- Average return on equity (ROE) among peers: -402.20%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Longevity Health Holdings, Inc. (XAGE) | $-5.87 Million | 0.00% | N/A | $737.40K |
| Acme United Corporation (ACU) | $20.60 Million | 6.31% | 1.00x | $158.51 Million |
| Bruush Oral Care Inc. (BRSHF) | $163.14K | -5449.60% | 11.70x | $10.10K |
| Park Ha Biological Technology Co., Ltd. (BYAH) | $150.28K | 127.30% | 15.76x | $12.69 Million |
| Church & Dwight Company Inc (CHD) | $2.06 Billion | 16.97% | 0.99x | $21.50 Billion |
| Colgate-Palmolive Company (CL) | $197.00 Million | 1218.27% | 60.73x | $70.06 Billion |
| The Clorox Company (CLX) | $932.80 Million | 23.81% | 1.34x | $10.75 Billion |
| Coty Inc (COTY) | $1.62 Billion | 10.40% | 3.00x | $1.67 Billion |
| Carmell Therapeutics Corporation (CTCX) | $-37.79 Million | 0.00% | 0.00x | $4.61 Million |
| Big Tree Cloud Holdings Limited Ordinary Shares (DSY) | $57.19 Million | 0.22% | 0.04x | $5.78 Million |
| Estee Lauder Companies Inc (EL) | $1.97 Billion | 24.34% | 1.71x | $20.39 Billion |
About Longevity Health Holdings, Inc.
Longevity Health Holdings, Inc., a bio-aesthetics company, focuses on developing, manufacturing, and marketing cosmetic skincare and haircare products. The company utilizes Carmell Secretome and Elevai Exosomes to support skin and hair health. Its Carmell Secretome consists of growth factors, proteins, and peptides extracted from allogeneic human platelets; and Elevai Exosomes constains growth fa… Read more